NRX Pharmaceuticals (NRXP) has shared an announcement.
On March 28, 2024, the Company made a significant announcement regarding a Reverse Stock Split, aiming to adjust its share structure. This corporate action, detailed in a press release, is important for investors to note, although it is not considered an official filing under the Securities Exchange Act regulations. The move could have implications for the market value and trading of the company’s shares.
See more insights into NRXP stock on TipRanks’ Stock Analysis page.
